ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 31 filers reported holding ARGOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $18,000 | -18.2% | 119,515 | 0.0% | 0.00% | – |
| Q3 2017 | $22,000 | -81.5% | 119,515 | +390.7% | 0.00% | -100.0% |
| Q4 2016 | $119,000 | -1.7% | 24,358 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $121,000 | -18.8% | 24,358 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $149,000 | -34.4% | 24,358 | -31.5% | 0.00% | -50.0% |
| Q1 2016 | $227,000 | +312.7% | 35,535 | +50.2% | 0.00% | – |
| Q4 2015 | $55,000 | -51.8% | 23,655 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $114,000 | -29.6% | 23,655 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $162,000 | -23.2% | 23,655 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $211,000 | +41.6% | 23,655 | +59.2% | 0.00% | 0.0% |
| Q4 2014 | $149,000 | -22.8% | 14,861 | -22.5% | 0.00% | 0.0% |
| Q3 2014 | $193,000 | -10.6% | 19,180 | -28.6% | 0.00% | 0.0% |
| Q2 2014 | $216,000 | -12.2% | 26,867 | +9.2% | 0.00% | -50.0% |
| Q1 2014 | $246,000 | – | 24,612 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $4,808,000 | 16.67% |
| Pharmstandard International S.A. | 5,120,604 | $1,859,000 | 6.44% |
| SANDERS MORRIS HARRIS LLC | 141,212 | $52,000 | 0.02% |
| ELEMENT CAPITAL MANAGEMENT LLC | 82,808 | $30,000 | 0.01% |
| WEDBUSH SECURITIES INC | 89,500 | $32,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $73,000 | 0.00% |
| LMR Partners LLP | 45,017 | $16,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 129,046 | $46,000 | 0.00% |
| STATE STREET CORP | 11,900 | $4,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 193,294 | $70,000 | 0.00% |